等待开盘 05-12 09:30:00 美东时间
-0.460
-3.60%
ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced receipt of a Medical Device License (MDL)
04-21 04:10
ClearPoint Neuro receives EU certification for its navigation software, expanding brain surgery access as the company reports strong revenue growth and outlines higher sales expectations for 2026.
01-24 00:16
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining mor...
2025-11-03 21:14
U.S. stocks were mixed, with the Dow Jones index falling around 0.1% on Tuesday. Shares of The Hain Celestial Group, Inc. (NASDAQ:HAIN) shares gained 34.2% to $9.16 after the company reported better-than-expected fourth-quarter adjusted EPS results. The company reported fourth quarter adjusted earni...
2024-08-27 22:38
Lake Street analyst Frank Takkinen maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and raises the price target from $11 to $15.
2024-08-27 20:54
04:39 PM EDT, 08/26/2024 (MT Newswires) -- ClearPoint Neuro (CLPT) said Monday that it has made a full early repayment of principal and interest on a $10 million convertible note January 2025 on Friday. The company said the note was held by PTC Therapeutics (PTCT). Shares of the company were up abou...
2024-08-27 04:39